The US Food and Drug Administration (FDA) has confirmed a significant recall of prazosin hydrochloride capsules, a drug widely prescribed for high blood pressure and post-traumatic stress disorder (PTSD), after routine testing detected a nitrosamine impurity—a chemical linked to cancer.
The voluntary recall, initiated by Teva Pharmaceuticals USA on 7 October 2025, affects more than 580,000 bottles distributed nationwide. Nitrosamines are a class of compounds that, in certain forms and concentrations, are considered probable human carcinogens.
